<SEC-DOCUMENT>0000882095-20-000009.txt : 20200430
<SEC-HEADER>0000882095-20-000009.hdr.sgml : 20200430
<ACCEPTANCE-DATETIME>20200430160801
ACCESSION NUMBER:		0000882095-20-000009
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200430
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200430
DATE AS OF CHANGE:		20200430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES INC
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19731
		FILM NUMBER:		20835704

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-kq120earningspre.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:f38e0b93580f40e7be4fadd820783fe1,x:99319c81e5a64e78a36e648e81bd7ea1-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:sheci="http://fasb.org/stm/sheci/2020-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2020-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2020-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2020-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2020-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2020-01-31" xmlns:equity="http://fasb.org/dis/equity/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ides="http://fasb.org/dis/ides/2020-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2020-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2020-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2020-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2020-01-31" xmlns:ei="http://fasb.org/dis/ei/2020-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2020-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2020-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2020-01-31" xmlns:srt-all="http://fasb.org/srt-all/2020-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2020-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2020-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2020-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2020-01-31" xmlns:se="http://fasb.org/dis/se/2020-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2020-01-31" xmlns:hco="http://fasb.org/dis/hco/2020-01-31" xmlns:soi="http://fasb.org/stm/soi/2020-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2020-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:debt="http://fasb.org/dis/debt/2020-01-31" xmlns:spc="http://fasb.org/stm/spc/2020-01-31" xmlns:ts="http://fasb.org/dis/ts/2020-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:rd="http://fasb.org/dis/rd/2020-01-31" xmlns:sr="http://fasb.org/dis/sr/2020-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2020-01-31" xmlns:guar="http://fasb.org/dis/guar/2020-01-31" xmlns:te="http://fasb.org/dis/te/2020-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2020-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:ni="http://fasb.org/dis/ni/2020-01-31" xmlns:dr="http://fasb.org/dis/dr/2020-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2020-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2020-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2020-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2020-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2020-01-31" xmlns:iago="http://fasb.org/dis/iago/2020-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2020-01-31" xmlns:con="http://fasb.org/dis/con/2020-01-31" xmlns:leas="http://fasb.org/dis/leas/2020-01-31" xmlns:com="http://fasb.org/stm/com/2020-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:inv="http://fasb.org/dis/inv/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2020-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2020-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2020-01-31" xmlns:oi="http://fasb.org/dis/oi/2020-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2020-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2020-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:cn-part="http://fasb.org/cn-part/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2020-01-31" xmlns:srt-std="http://fasb.org/srt-std/2020-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2020-01-31" xmlns:re="http://fasb.org/dis/re/2020-01-31" xmlns:ir="http://fasb.org/dis/ir/2020-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2020-01-31" xmlns:soc="http://fasb.org/stm/soc/2020-01-31" xmlns:gild="http://www.gilead.com/20200430" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2020-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2020-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2020-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2020-01-31" xmlns:regop="http://fasb.org/dis/regop/2020-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2020-01-31" xmlns:ero="http://fasb.org/dis/ero/2020-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2020-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2020-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:invco="http://fasb.org/dis/invco/2020-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2020-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2020-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2020-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2020-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2020-01-31" xmlns:aro="http://fasb.org/dis/aro/2020-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2020-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2020-01-31" xmlns:pay="http://fasb.org/dis/pay/2020-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2020-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2020-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2020-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2020-01-31" xmlns:eps="http://fasb.org/dis/eps/2020-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2020-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2020-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:crcrb="http://fasb.org/dis/crcrb/2020-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2020-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2020-01-31" xmlns:lea="http://fasb.org/dis/lea/2020-01-31" xmlns:disops="http://fasb.org/dis/disops/2020-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2020-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2020-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2020-01-31" xmlns:nt="http://fasb.org/dis/nt/2020-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2020-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2020-01-31" xmlns:cce="http://fasb.org/dis/cce/2020-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2020-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2020-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2020-01-31" xmlns:acec="http://fasb.org/dis/acec/2020-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2020-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2020-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2020-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2020-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2020-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2020-01-31" xmlns:ru="http://fasb.org/dis/ru/2020-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2020-01-31" xmlns:foct="http://fasb.org/dis/foct/2020-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2020-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2020-01-31" xmlns:diha="http://fasb.org/dis/diha/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ap="http://fasb.org/dis/ap/2020-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:eui="http://fasb.org/dis/eui/2020-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1Cover" name="dei:AmendmentFlag" id="Fact-7190B9B0D05C3A2EC0D6C236D012AE66-wk-Fact-7190B9B0D05C3A2EC0D6C236D012AE66" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1Cover" name="dei:EntityCentralIndexKey" id="Fact-EFBEB44A60131AFBA631C23672EFEF38-wk-Fact-EFBEB44A60131AFBA631C23672EFEF38">0000882095</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="gild-20200430.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1Cover">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-30</xbrli:startDate>
			<xbrli:endDate>2020-04-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s46F681DBB431D7553FC19D2B8D723C58"></a></div><div><div style="line-height:120%;text-align:right;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-weight:bold;">Washington, D.C. 20549 </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:31.384015594541907%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d9904439e104-wk-Fact-DF82DCF05BAB832A1793C22CB3B9EC20" name="dei:DocumentType" contextRef="D2020Q1Cover"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:31.384015594541907%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-weight:bold;">CURRENT REPORT</span></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of</span></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-weight:bold;">The Securities Exchange Act of 1934 </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;">DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):</span><span style="font-family:inherit;font-size:11pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:11pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d9904439e144-wk-Fact-255D5D3DF8FEAE60F6A0C22D1B740727" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1Cover" format="ixt:datemonthdayyearen">April 30, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:11pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:33%;"></td><td style="width:4%;"></td><td style="width:24%;"></td><td style="width:4%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:20pt;"><span><ix:nonNumeric id="d9904439e187-wk-Fact-37A3595D653867DEBFF5C22D84AEAF5B" name="dei:EntityRegistrantName" contextRef="D2020Q1Cover"><span style="font-size:20pt;font-weight:bold;">GILEAD SCIENCES, INC.</span></ix:nonNumeric></span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(Exact name of registrant as specified in its charter) </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:40%;"></td><td style="width:20%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e207-wk-Fact-118C3651552539AFE738C22E30648673" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1Cover" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e212-wk-Fact-20A8B0DC864BE2EFDE65C22E801CB591" name="dei:EntityFileNumber" contextRef="D2020Q1Cover">0-19731</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e217-wk-Fact-C8E6A5782E9B739EFD96C22EC312904B" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1Cover">94-3047598</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(State or Other Jurisdiction of Incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(Commission File No.)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(IRS Employer Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d9904439e238-wk-Fact-F4FA22BB811F15F7E2E9C22F42E326B5" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1Cover"><span style="font-weight:bold;">333 Lakeside Drive</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">, </span><span><ix:nonNumeric id="d9904439e243-wk-Fact-BB1321B8A7E7DE6813E3C22F9BBBC632" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1Cover"><span style="font-weight:bold;">Foster City</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">, </span><span><ix:nonNumeric id="d9904439e248-wk-Fact-404C5BBD50C47C5C3990C230085D1C28" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1Cover" format="ixt-sec:stateprovnameen"><span style="font-weight:bold;">California</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(Address of principal executive offices)</span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d9904439e257-wk-Fact-E0F31D782567E1A9AA33C2305C8A0C36" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1Cover"><span style="font-weight:bold;">94404</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(Zip Code)</span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e267-wk-Fact-4677EE869D4865770EA3C230AD01D01B" name="dei:CityAreaCode" contextRef="D2020Q1Cover">650</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">-</span><span><ix:nonNumeric id="d9904439e271-wk-Fact-08FA5700662AF1094800C23103A5AC2D" name="dei:LocalPhoneNumber" contextRef="D2020Q1Cover"><span style="font-weight:bold;">574-3000</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:33%;"></td><td style="width:4%;"></td><td style="width:24%;"></td><td style="width:4%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Applicable</span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(Former name or former address, if changed since last report)</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span><ix:nonNumeric id="d9904439e327-wk-Fact-3776C3F408C418D58539C2316FAB3DD2" name="dei:WrittenCommunications" contextRef="D2020Q1Cover" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial Unicode MS;font-size:10pt;"></span><span style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span><ix:nonNumeric id="d9904439e335-wk-Fact-0C7AA48C8579C8211A3EC231D6FDE33E" name="dei:SolicitingMaterial" contextRef="D2020Q1Cover" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial Unicode MS;font-size:10pt;"></span><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span><ix:nonNumeric id="d9904439e343-wk-Fact-931C4D3BA33B787DC0C6C2321A5EC9CB" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1Cover" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial Unicode MS;font-size:10pt;"></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span><ix:nonNumeric id="d9904439e351-wk-Fact-28ABB04CC31D407D8BA8C23294C3C141" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1Cover" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial Unicode MS;font-size:10pt;"></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:37%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:38%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e404-wk-Fact-70F24BF8C620FD66F9EDC232F78F5614" name="dei:Security12bTitle" contextRef="D2020Q1Cover">Common Stock, par value, $0.001 per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e414-wk-Fact-A2982D9EA0846DE0CEA5C233313362C1" name="dei:TradingSymbol" contextRef="D2020Q1Cover">GILD</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d9904439e424-wk-Fact-864EB48A93A357C64B7EC2337598C76B" name="dei:SecurityExchangeName" contextRef="D2020Q1Cover" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Emerging growth company  </span><span><ix:nonNumeric id="d9904439e432-wk-Fact-05274D557B34F5ACE0E8C233D7ECA287" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1Cover" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family:Wingdings;font-size:9pt;">&#168;</span></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Section 2 - FINANCIAL INFORMATION</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.02 </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations and Financial Condition.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;">April&#160;30, 2020</span><span style="font-family:inherit;font-size:10pt;">, Gilead Sciences, Inc., a Delaware corporation (Gilead), issued a press release announcing its financial results for the quarter ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. A copy of the press release is filed as </span><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991earningspressrel.htm"><span style="font-family:inherit;font-size:10pt;">Exhibit 99.1</span></a><span style="font-family:inherit;font-size:10pt;"> to this report. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gilead has presented certain financial information in accordance with U.S. generally accepted accounting principles (GAAP) and also on a non-GAAP basis. Management believes this non-GAAP information is useful for investors, when considered in conjunction with Gilead&#8217;s GAAP financial statements, because management uses such information internally for its operating, budgeting and financial planning purposes. Non-GAAP information is not prepared under a comprehensive set of accounting rules and should only be used to supplement an understanding of Gilead&#8217;s operating results as reported under GAAP. Non-GAAP measures may be defined and calculated differently by other companies in the same industry.  A reconciliation between GAAP and non-GAAP financial information is provided in the tables on pages 9 and 10 of the press release filed as Exhibit 99.1 to this report.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information in this Form 8-K and the exhibit attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Section 9 - FINANCIAL STATEMENTS AND EXHIBITS</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01</span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:86.74463937621833%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:19%;"></td><td style="width:3%;"></td><td style="width:78%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991earningspressrel.htm"><span style="font-family:inherit;font-size:10pt;">99.1</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991earningspressrel.htm"><span style="font-family:inherit;font-size:10pt;">Press Release, issued by Gilead Sciences, Inc. on April 30, 2020</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;">&#160;</span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:42.8849902534113%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Registrant)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ ANDREW D. DICKINSON</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Andrew D. Dickinson</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Executive Vice President and Chief Financial Officer</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date:  </span><span style="font-family:inherit;font-size:10pt;">April&#160;30, 2020</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit Index</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:86.74463937621833%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:19%;"></td><td style="width:3%;"></td><td style="width:78%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991earningspressrel.htm"><span style="font-family:inherit;font-size:10pt;">99.1</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991earningspressrel.htm"><span style="font-family:inherit;font-size:10pt;">Press Release, issued by Gilead Sciences, Inc. on April 30, 2020</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991earningspressrel.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sAD126204D64D30077F759D2C0F95FA84"></a></div><div><div style="line-height:120%;text-align:right;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;"><br></font></div><div style="line-height:120%;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;"><img src="gileadlogocolora001a18.jpg" alt="gileadlogocolora001a18.jpg" style="height:78px;width:273px;"></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:18%;"></td><td style="width:21%;"></td><td style="width:17%;"></td><td style="width:29%;"></td><td style="width:15%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CONTACTS:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Investors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Media</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Andrew Dickinson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amy Flood</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(650) 524-0862</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(650) 522-5643</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Douglas Maffei, Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(650) 522-2739</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">For Immediate Release</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GILEAD  SCIENCES  ANNOUNCES  </font><font style="font-family:inherit;font-size:11pt;color:#000000;font-weight:bold;text-decoration:none;">FIRST  QUARTER</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:11pt;color:#000000;font-weight:bold;text-decoration:none;">2020</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;&#32;FINANCIAL  RESULTS</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">- Product Sales of </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">$5.5 billion</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">&#32;-</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">- Diluted EPS of </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">$1.22</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">&#32;per share -</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">- Non-GAAP Diluted EPS of </font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">$1.68</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">&#32;per share -</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Foster City, CA, </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">April&#160;30, 2020</font><font style="font-family:inherit;font-size:11pt;">&#32;- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2020</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;Gilead&#8217;s performance during the first quarter demonstrates our continued progress and highlights the strength of our underlying business. While we are prepared to navigate the uncertainty and short-term impact from the pandemic, we are confident in our ability to deliver on our long-term goals,&#8221; said Daniel O&#8217;Day, Chairman and Chief Executive Officer of Gilead Sciences. &#8220;Our focus at this time is on both our work with remdesivir and our ongoing commitments to the people who depend on our medicines today.&#8221;</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">First Quarter Financial Results</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The financial results that follow represent a year-over-year comparison of the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;to the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. Total revenues for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;were </font><font style="font-family:inherit;font-size:11pt;">$5.5 billion</font><font style="font-family:inherit;font-size:11pt;">, an increase of </font><font style="font-family:inherit;font-size:11pt;">5%</font><font style="font-family:inherit;font-size:11pt;">&#32;compared to the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. Net income for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;was </font><font style="font-family:inherit;font-size:11pt;">$1.6 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;or </font><font style="font-family:inherit;font-size:11pt;">$1.22</font><font style="font-family:inherit;font-size:11pt;">&#32;per diluted share, a decrease of </font><font style="font-family:inherit;font-size:11pt;">21%</font><font style="font-family:inherit;font-size:11pt;">&#32;compared to the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. Non-GAAP net income for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2020</font><font style="font-family:inherit;font-size:11pt;">&#32;was </font><font style="font-family:inherit;font-size:11pt;">$2.1 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;or </font><font style="font-family:inherit;font-size:11pt;">$1.68</font><font style="font-family:inherit;font-size:11pt;">&#32;per diluted share, essentially flat compared to the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,467</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,200</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalty, contract and other revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,281</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Gilead</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,551</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP net income attributable to Gilead</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,139</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,141</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.54</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;">diluted earnings per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.67</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">________________________________</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Starting in 2020, Gilead no longer regularly excludes share-based compensation expense from its non-GAAP financial information. To conform to this change, the prior period non-GAAP financial information has been recast to include share-based compensation expense. A reconciliation between GAAP and non-GAAP financial information is provided in the tables on pages 9 and 10.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gilead Sciences, Inc.  333 Lakeside Drive  Foster City, CA  94404  USA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">www.gilead.com</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">phone (650) 574-3000  facsimile (650) 578-9264</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s78DE36338745DE0D7B639D2C0FCB5C59"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Product Sales</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total product sales for the first quarter 2020 were </font><font style="font-family:inherit;font-size:11pt;">$5.5 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;compared to </font><font style="font-family:inherit;font-size:11pt;">$5.2 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;for the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. Product sales for the first quarter 2020 were </font><font style="font-family:inherit;font-size:11pt;">$4.0 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;in the United States, </font><font style="font-family:inherit;font-size:11pt;">$927 million</font><font style="font-family:inherit;font-size:11pt;">&#32;in Europe and </font><font style="font-family:inherit;font-size:11pt;">$551 million</font><font style="font-family:inherit;font-size:11pt;">&#32;in other locations. Product sales for the </font><font style="font-family:inherit;font-size:11pt;">first quarter</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">&#32;were </font><font style="font-family:inherit;font-size:11pt;">$3.8 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;in the United States, </font><font style="font-family:inherit;font-size:11pt;">$882 million</font><font style="font-family:inherit;font-size:11pt;">&#32;in Europe and </font><font style="font-family:inherit;font-size:11pt;">$522 million</font><font style="font-family:inherit;font-size:11pt;">&#32;in other locations. Total product sales for the first quarter 2020 benefited from an estimated $200 million in revenue related to increased customer buying patterns and patient prescription trends, primarily in the United States, due to the coronavirus disease (COVID-19) pandemic. </font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">HIV product sales</font><font style="font-family:inherit;font-size:11pt;">&#32;were </font><font style="font-family:inherit;font-size:11pt;">$4.1 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;for the first quarter 2020 compared to </font><font style="font-family:inherit;font-size:11pt;">$3.6 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;for the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. The </font><font style="font-family:inherit;font-size:11pt;">increase</font><font style="font-family:inherit;font-size:11pt;">&#32;was primarily driven by higher sales volume as a result of the continued uptake of Biktarvy</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg) and increased customer buying patterns and patient prescription trends due to the pandemic.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Chronic hepatitis C virus (HCV) product sales</font><font style="font-family:inherit;font-size:11pt;">&#32;were </font><font style="font-family:inherit;font-size:11pt;">$729 million</font><font style="font-family:inherit;font-size:11pt;">&#32;for the first quarter 2020 compared to </font><font style="font-family:inherit;font-size:11pt;">$790 million</font><font style="font-family:inherit;font-size:11pt;">&#32;for the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. The </font><font style="font-family:inherit;font-size:11pt;">decline</font><font style="font-family:inherit;font-size:11pt;">&#32;was primarily due to lower average net selling price.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Yescarta</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(axicabtagene ciloleucel) generated </font><font style="font-family:inherit;font-size:11pt;">$140 million</font><font style="font-family:inherit;font-size:11pt;">&#32;in sales during the first quarter 2020 compared to </font><font style="font-family:inherit;font-size:11pt;">$96 million</font><font style="font-family:inherit;font-size:11pt;">&#32;for the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. The </font><font style="font-family:inherit;font-size:11pt;">increase</font><font style="font-family:inherit;font-size:11pt;">&#32;was primarily driven by continued expansion in Europe. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other product sales, which include Vemlidy</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(tenofovir alafenamide 25 mg), Viread</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(tenofovir disoproxil fumarate 300 mg), Letairis</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(ambrisentan 5 mg and 10 mg), Ranexa</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(ranolazine 500 mg and 1000 mg), Zydelig</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(idelalisib 150 mg), AmBisome</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:11pt;">(amphotericin B liposome for injection 50 mg/vial) and Cayston</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;(aztreonam for inhalation solution 75 mg/vial), were </font><font style="font-family:inherit;font-size:11pt;">$464 million</font><font style="font-family:inherit;font-size:11pt;">&#32;for the first quarter 2020 compared to </font><font style="font-family:inherit;font-size:11pt;">$696 million</font><font style="font-family:inherit;font-size:11pt;">&#32;for the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. The </font><font style="font-family:inherit;font-size:11pt;">decrease</font><font style="font-family:inherit;font-size:11pt;">&#32;was primarily due to the expected declines in Ranexa and Letairis sales after generic entries in February and May 2019, respectively. </font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Operating Expenses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses (R&amp;D)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,057</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP R&amp;D expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">932</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses (SG&amp;A) - GAAP and non-GAAP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,076</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,030</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">During the first quarter 2020, compared to the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">R&amp;D expenses and non-GAAP R&amp;D expenses </font><font style="font-family:inherit;font-size:11pt;">increased</font><font style="font-family:inherit;font-size:11pt;">&#32;primarily due to Gilead&#8217;s ramp up of remdesivir, an investigational antiviral for the treatment of COVID-19, including approximately $50 million of manufacturing scale-up and clinical trial costs, partially offset by lower clinical trial expenses as a result of Gilead&#8217;s pause or postponement of other clinical trials resulting from the pandemic.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">SG&amp;A expenses and non-GAAP SG&amp;A expenses </font><font style="font-family:inherit;font-size:11pt;">increased</font><font style="font-family:inherit;font-size:11pt;">&#32;primarily due to higher promotional expenses in the United States.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Other Income (Expense), Net</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP other income (expense), net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">During the first quarter 2020, compared to the same period in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other income (expense), net </font><font style="font-family:inherit;font-size:11pt;">decreased</font><font style="font-family:inherit;font-size:11pt;">&#32;by $525 million primarily due to unfavorable changes in the fair value of investments in equity securities, largely resulting from Gilead&#8217;s equity investment in Galapagos NV.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Cash, Cash Equivalents and Marketable Debt Securities</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">March 31, 2020</font><font style="font-family:inherit;font-size:11pt;">, Gilead had </font><font style="font-family:inherit;font-size:11pt;">$24.3 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;of cash, cash equivalents and marketable debt securities, compared to </font><font style="font-family:inherit;font-size:11pt;">$25.8 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:11pt;">. During the first quarter 2020, Gilead generated </font><font style="font-family:inherit;font-size:11pt;">$1.4 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;in operating cash flow, repaid </font><font style="font-family:inherit;font-size:11pt;">$500 million</font><font style="font-family:inherit;font-size:11pt;">&#32;of debt, paid cash dividends of </font><font style="font-family:inherit;font-size:11pt;">$874 million</font><font style="font-family:inherit;font-size:11pt;">&#32;and utilized </font><font style="font-family:inherit;font-size:11pt;">$1.3 billion</font><font style="font-family:inherit;font-size:11pt;">&#32;on stock repurchases. Subsequent to March 31, 2020, Gilead paid approximately $4.9 billion in cash for the acquisition of Forty Seven, Inc. (Forty Seven)</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Corporate Highlights</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">During the first quarter 2020, Gilead continued to make progress in advancing work across each of three long-term ambitions laid out in its corporate strategy: (i) to bring 10+ transformative therapies to patients in the next 10 years; (ii) to be the biotech employer and partner of choice; and (iii) to deliver shareholder value in a sustainable and responsible manner. This progress occurred amid challenges posed by the COVID-19 pandemic and an increased focus across the organization on rapidly advancing remdesivir.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Corporate Development:</font><font style="font-family:inherit;font-size:11pt;">&#32;In March, Gilead reached an agreement to acquire Forty Seven for approximately $4.9 billion, gaining a drug candidate, magrolimab, which is currently in Phase 1b/2 clinical studies for a number of hematological cancers. The acquisition also brings a team with expertise in immuno-oncology, an area of increased focus for Gilead. The acquisition closed in April and Gilead is now working to accelerate progress of magrolimab and grow Gilead&#8217;s immuno-oncology pipeline. Approximately $4.6 to $4.8 billion of acquired in-process R&amp;D and other expenses, or $3.70 to $3.80 per diluted share, are expected to be recognized in earnings in the second quarter 2020 and will be excluded from the non-GAAP financial results. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead entered into several additional agreements to advance its business, including a four-year strategic collaboration with Second Genome, Inc. to identify biomarkers associated with clinical response in up to five of Gilead&#8217;s pipeline compounds in inflammation, fibrosis and other diseases, and to identify potential new targets and drug candidates for the treatment of inflammatory bowel disease. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Pipeline Progress: </font><font style="font-family:inherit;font-size:11pt;">Gilead continued to advance several pipeline programs during the first quarter 2020. Kite, a Gilead company (Kite), achieved two key regulatory milestones for KTE-X19, an investigational cell therapy for the treatment of relapsed or refractory mantle cell lymphoma. In Europe, the marketing authorization application for KTE-X19 was fully validated and is now under review by the European Medicines Agency, and in the United States, the U.S. Food and Drug Administration (FDA) accepted the Biologics License Application and granted Priority Review designation.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In HIV, key data were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in March for several approved and investigational HIV products. This included new clinical study data for Gilead&#8217;s investigational HIV-1 capsid inhibitor lenacapavir as a potential long-acting treatment for people living with HIV, results from a study of the experimental toll-like receptor 7 agonist vesatolimod, which is part of Gilead&#8217;s HIV cure research program, and additional data on Biktarvy as a treatment for HIV and Descovy for the prevention of HIV. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Expanded Approval: </font><font style="font-family:inherit;font-size:11pt;">In March, FDA approved Epclusa for children ages 6 and older (or weighing at least 17 kg) with HCV. Epclusa is the first pan-genotypic, protease inhibitor-free regimen approved in the United States for children and adults. An estimated 23,000 to 46,000 children in the United States are living with HCV. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">New Board Member:</font><font style="font-family:inherit;font-size:11pt;">&#32;In January, Sandra J. Horning, M.D., who retired in 2019 as Chief Medical Officer and Global Head of Product Development at Roche, joined Gilead&#8217;s Board of Directors. Dr. Horning&#8217;s appointment brings significant industry and drug development expertise to the Board, as Gilead seeks to bring forward transformative new therapies as part of its corporate strategy.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Recent Developments and Insights</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Gilead&#8217;s COVID-19 Response: </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Advancing remdesivir:</font><font style="font-family:inherit;font-size:11pt;">&#32;Gilead made rapid progress in advancing remdesivir as a potential treatment for COVID-19. Gilead initiated two open-label Phase 3 studies in February (the Gilead SIMPLE studies). Additional global studies are ongoing, including a global, placebo-controlled trial being led by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), as well as more recently initiated studies through the World Health Organization and INSERM in France.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Yesterday, NIAID announced that the preliminary results from their trial met the primary endpoint, and remdesivir was found to shorten the time to recovery for hospitalized patients with COVID-19 when compared with a placebo. Gilead also announced topline results from the first Gilead SIMPLE study evaluating 5-day and 10-day dosing durations of remdesivir in patients with severe COVID-19 disease. The study demonstrated similar clinical improvements in patients with severe symptoms of COVID-19, regardless of whether they received five or ten days of treatment.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead also took significant steps to expand remdesivir manufacturing production, announcing the expectation that more than 140,000 treatment courses of remdesivir will be manufactured by the end of May 2020. As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be manufactured by December 2020, with plans to be able to produce several million treatment courses in 2021. However, these projections assume a 10-day dosing duration, and the number of treatment courses expected to be available may actually be higher based on the recent topline results from the first Gilead SIMPLE study, which suggests the potential for certain patients to be treated with a shorter dosing duration.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Employee health, safety and productivity support: </font><font style="font-family:inherit;font-size:11pt;">Gilead took steps and provided resources to help ensure the health, safety and productivity of its employees, with most staff in offices around the world being asked to work remotely. Individuals with physical-location dependent roles are reporting to work, and Gilead has implemented social distancing protocols, increased cleaning and sanitization and other measures to protect those employees. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead is providing additional benefits to its employees during this time, including work-from-home and certain childcare expense reimbursements, employee well-being resources, essential onsite services pay for those physical-location dependent roles, and a revised volunteer medical service paid leave policy for its employees with medical training, such as doctors, nurses and physician assistants, to help treat patients. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Community support: </font><font style="font-family:inherit;font-size:11pt;">Gilead announced the entirety of its initial supply of remdesivir of 1.5 million individual doses will be donated free of charge through current access programs and clinical trials and for broader distribution following any potential regulatory authorizations. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead announced the creation of the global Gilead CARES (COVID-19 Acute Relief and Emergency Support) Grantee Fund to provide financial support to current nonprofit grantees facing an imminent closure or termination of vital services due to losses attributable to the pandemic. The fund will provide up to $20 million in donations to these groups. Gilead also announced the following community donations: $1 million to the San Mateo County Strong Fund, which is providing financial support to individuals, small businesses and nonprofit organizations in San Mateo County where Gilead is based, and $1 million to the Mayor&#8217;s Fund for Los Angeles, which is providing support for families and small businesses, relief for healthcare workers and other services in response to the COVID-19 pandemic.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Supply chain and access to medicines</font><font style="font-family:inherit;font-size:11pt;">: There are currently no significant manufacturing concerns or supply shortages with any Gilead products. Gilead sources various raw materials and active pharmaceutical ingredient (API) for Gilead&#8217;s products from a number of suppliers. Gilead has adequate supply of its products and does not expect any significant risk or disruption to its supply chain for the foreseeable future.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Clinical trials and research</font><font style="font-family:inherit;font-size:11pt;">: Following a review of its clinical trials and ongoing research, Gilead has determined to continue its fully enrolled trials, temporarily postpone new trials and pause enrollment in other trials. Gilead remains committed to commencing enrollment and initiating new studies when it is appropriate to do so. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Impact of COVID-19:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">First Quarter 2020 </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Total product sales: </font><font style="font-family:inherit;font-size:11pt;">Total product sales for the first quarter 2020 included an estimated $200 million in revenue related to increased customer buying patterns and patient prescription trends due to the pandemic, primarily in the United States, which is expected to reverse itself over subsequent quarters. </font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Research and development expense: </font><font style="font-family:inherit;font-size:11pt;">The approximately $50 million in R&amp;D expenses related to remdesivir exceeded the savings from Gilead&#8217;s pause on enrollment and temporary postponement of clinical trials resulting from the pandemic during the first quarter 2020.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Outlook </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">There is significant uncertainty about the progression and ultimate impact of the pandemic on Gilead&#8217;s business and operations. While COVID-19 did not materially impact Gilead&#8217;s first quarter results, Gilead anticipates that COVID-19 could impact its business in the short-term due to factors such as fewer patients accessing treatment for conditions such as HIV and HCV, however, the impact of these developments is uncertain. In addition to this uncertainty, during the first quarter 2020, Gilead began advancing remdesivir and rapidly expanding its manufacturing production. The total investments in remdesivir, primarily to expand manufacturing production, throughout 2020 could be material, but the amount, timing and accounting for the investments as well as the potential to recoup Gilead&#8217;s at-risk investments at some point in the future are dependent on clinical trial and regulatory outcomes. Where authorized by regulatory authorities, Gilead will focus on making remdesivir both accessible and affordable to governments and patients around the world. Further insights on the impact of the pandemic to date and remdesivir will be provided on the first quarter earnings call, and in Gilead&#8217;s first quarter 2020 earnings slides.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead will continue to monitor the impact of the COVID-19 pandemic and expects to provide additional insights and outlook on its second quarter 2020 earnings call when Gilead expects there will be additional clarity on the duration and magnitude of the impact of the COVID-19 pandemic and the development of remdesivir.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Non-GAAP Financial Information</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The information presented in this document has been prepared in accordance with U.S. generally accepted accounting principles (GAAP), unless otherwise noted as non-GAAP. Management believes non-GAAP information is useful for investors, when considered in conjunction with Gilead&#8217;s GAAP financial information, because management uses such information internally for its operating, budgeting and financial planning purposes. Non-GAAP information is not prepared under a comprehensive set of accounting rules and should only be used to supplement an understanding of Gilead&#8217;s operating results as reported under GAAP. Non-GAAP financial information excludes acquisition-related expenses including amortization and impairments of purchased intangible assets, charges for in-process research and development, up-front collaboration and licensing expenses, and other items that are considered unusual or not representative of underlying trends of Gilead&#8217;s business, fair value adjustments of equity securities and discrete tax charges or benefits associated with changes in tax related laws and guidelines. Although Gilead consistently excludes the amortization of purchased intangible assets from the non-GAAP financial information, management believes that it is important for investors to understand that such intangible assets were recorded as part of acquisitions and contribute to ongoing revenue generation.</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:11pt;">Non-GAAP measures may be defined and calculated differently by other companies in the same industry. Reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures are provided in the tables on pages 9 and 10.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Conference Call</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">At 4:30 p.m. Eastern Time today, Gilead&#8217;s management will host a conference call and a simultaneous webcast to discuss the company&#8217;s first quarter&#160;2020&#160;financial results and provide a business update. The live webcast of the call can be accessed at Gilead&#8217;s Investors page at&#160;http://investors.gilead.com. Please connect to the website at least 15 minutes prior to the start of the call to allow adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 1898512 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, May 2, 2020. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the conference ID 1898512. The webcast will be archived on&#160;www.gilead.com&#160;for one year.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">About Gilead Sciences </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than </font><font style="font-family:inherit;font-size:11pt;">35</font><font style="font-family:inherit;font-size:11pt;">&#32;countries worldwide, with headquarters in Foster City, California.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Forward-Looking Statements</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Statements included in this press release that are not historical in nature are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Gilead cautions readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the risks and uncertainties related to the impact of the COVID-19 pandemic on Gilead&#8217;s business, financial condition and results of operations; the risks and uncertainties related to the development and potential distribution of remdesivir as a treatment for COVID-19, including the possibility that remdesivir may not receive regulatory approval and may never be successfully commercialized and that Gilead may be unable to recoup the expenses incurred to date and future expenses related to the development and production of remdesivir; the risk that Gilead may be unable to sufficiently scale up the production of remdesivir in the currently anticipated timelines and unable to meet future supply needs; Gilead&#8217;s ability to achieve its anticipated full year 2020 financial results, including as a result of potential adverse revenue impacts as a result of COVID-19 or increases in expenses due to the development and commercialization of remdesivir; Gilead&#8217;s ability to make progress on any of its long-term ambitions laid out in its corporate strategy; Gilead&#8217;s ability to accelerate or sustain revenues for its antiviral and other programs; Gilead&#8217;s ability to realize the potential benefits of acquisitions, collaborations or licensing arrangements, including those of or with Forty Seven and Second Genome, Inc.; the ability to initiate, progress or complete clinical trials within currently anticipated timeframes, including the ongoing clinical trials for remdesivir for the treatment of COVID-19; the risk that safety and efficacy data from clinical studies may not warrant further development of Gilead&#8217;s product candidates, including remdesivir, magrolimab, lenacapavir and vesatolimod; Gilead&#8217;s ability to submit new drug applications for new product candidates in the currently anticipated timelines; Gilead&#8217;s ability to receive regulatory approvals in a timely manner or at all, for new and current products, including FDA approval of filgotinib for the treatment of rheumatoid arthritis and FDA and European Commission approval of KTE-X19 for the treatment of relapsed or refractory mantle cell lymphoma; Gilead&#8217;s ability to successfully commercialize its products; the risk of potential disruptions to the manufacturing and supply chain of Gilead&#8217;s products; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products; a larger than anticipated shift in payer mix to more highly discounted payer segments; market share and price erosion caused by the introduction of generic versions of Gilead products; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; and other risks identified from time to time in Gilead&#8217;s reports filed with the U.S. Securities and Exchange Commission (the SEC). In addition, Gilead makes estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. Gilead bases its estimates on historical experience and on various other market specific and other relevant assumptions that it believes to be reasonable under the circumstances, the results of which form the basis </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There may be other factors of which Gilead is not currently aware that may affect matters discussed in the forward-looking statements and may also cause actual results to differ significantly from these estimates. Further, results for the quarter ended </font><font style="font-family:inherit;font-size:11pt;">March 31, 2020</font><font style="font-family:inherit;font-size:11pt;">&#160;are not necessarily indicative of operating results for any future periods. Information about these and other risks, uncertainties and factors can be found in Gilead&#8217;s periodic reports filed with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Gilead claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">All forward-looking statements are based on information currently available to Gilead and Gilead assumes no obligation to update or supplement any such forward-looking statements other than as required by law. Any forward-looking statements speak only as of the date hereof or as of the dates indicated in the statements.</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">#  #  #</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Gilead owns or has rights to various trademarks, copyrights and trade names used in its business, including the following: GILEAD</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, GILEAD SCIENCES</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, AMBISOME</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, ATRIPLA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, BIKTARVY</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, CAYSTON</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, COMPLERA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, DESCOVY</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, DESCOVY FOR PREP</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, EMTRIVA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, EPCLUSA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, EVIPLERA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, GENVOYA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, HARVONI</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, HEPSERA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, LETAIRIS</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, ODEFSEY</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, RANEXA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, SOVALDI</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, STRIBILD</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, TRUVADA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, TRUVADA FOR PREP</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, TYBOST</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, VEMLIDY</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, VIREAD</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, VOSEVI</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">, YESCARTA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;and ZYDELIG</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">LEXISCAN</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;is a registered trademark of Astellas U.S. LLC. MACUGEN</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;is a registered trademark of Bausch Health Ireland Limited. SYMTUZA</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;is a registered trademark of Janssen Sciences Ireland UC. TAMIFLU</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;is a registered trademark of Hoffmann-La Roche Inc. This report also refers to trademarks, service marks and trade names of other companies.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">For more information on Gilead Sciences, Inc., please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- more -</font></div></div><hr style="page-break-after:always"><div><a name="s77586C32A786A137D0689D2BD5776BFF"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions, except per share amounts)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:80%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Revenues:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Royalty, contract and other revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,281</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Cost of goods sold</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,057</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,076</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,030</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Total costs and expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,146</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,044</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Income from operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,237</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(241</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Income before provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,003</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,350</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Provision for income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">465</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,538</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,968</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net loss attributable to noncontrolling interest</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net income attributable to Gilead</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,551</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net income per share attributable to Gilead common stockholders - basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Shares used in per share calculation - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,262</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net income per share attributable to Gilead common stockholders - diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Shares used in per share calculation - diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,270</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,283</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Cash dividends declared per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="se4d77295949d4224ad72a8ae710181ae"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions, except percentages and per share amounts)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of goods sold reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP cost of goods sold</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related &#8211; amortization of purchased intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(266</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(283</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP cost of goods sold</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">703</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product gross margin reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP product gross margin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related &#8211; amortization of purchased intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP product gross margin</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.1 </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.0 </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Research and development expenses reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP research and development expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,057</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Up-front collaboration and licensing expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP research and development expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating margin reconciliation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP operating margin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Up-front collaboration and licensing expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related &#8211; amortization of purchased intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP operating margin</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.8 </font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other income (expense), net reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Losses (gains) from equity securities, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective tax rate reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP effective tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax effect of above non-GAAP adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP effective tax rate</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.7 </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income attributable to Gilead reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP net income attributable to Gilead</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Up-front collaboration and licensing expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related &#8211; amortization of purchased intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Losses (gains) from equity securities, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(191</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discrete tax charges</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP net income attributable to Gilead</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,141</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;- (Continued)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions, except percentages and per share amounts)</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diluted earnings per share reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP diluted earnings per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Up-front collaboration and licensing expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related &#8211; amortization of purchased intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Losses (gains) from equity securities, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discrete tax charges</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP diluted earnings per share</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.67</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-GAAP adjustment summary:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net adjustments </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total non-GAAP adjustments before tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">211</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax effect</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(91</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discrete tax charges</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total non-GAAP adjustments after tax</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">____________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Starting in 2020, Gilead no longer regularly excludes share-based compensation expense from its non-GAAP financial information. To conform to this change, the prior period non-GAAP financial information has been recast to include share-based compensation expense</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Amounts represent the subsequent reversal of the deferred tax assets established in the fourth quarter 2019. Such reversal arises from the amortization of the intangible assets that were transferred from a foreign subsidiary to Ireland and the United States</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Amounts represent restructuring, contingent consideration and/or other individually insignificant amounts</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Amounts may not sum due to rounding</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s476e7f1a1bcc438e8f4fcc2b84520089"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:74%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,907</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,582</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,502</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,117</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,117</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,316</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,733</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,627</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,683</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,218</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders&#8217; equity</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,650</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,627</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">________________________________</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;">&#32;&#32;&#32;&#32;As of </font><font style="font-family:inherit;font-size:8pt;">March 31, 2020</font><font style="font-family:inherit;font-size:8pt;">, there were </font><font style="font-family:inherit;font-size:8pt;">1,254 million</font><font style="font-family:inherit;font-size:8pt;">&#32;shares of common stock issued and outstanding</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="sb52711669e514191b36cf6d41c7283fa"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRODUCT SALES SUMMARY</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Atripla &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Atripla &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Atripla &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">95</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Biktarvy &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,412</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Biktarvy &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">181</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Biktarvy &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,693</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">793</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Complera / Eviplera &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Complera / Eviplera &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Complera / Eviplera &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Descovy &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">233</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Descovy &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Descovy &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">458</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Genvoya &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">612</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">728</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Genvoya &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Genvoya &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Odefsey &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Odefsey &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">106</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Odefsey &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">409</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">397</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stribild &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stribild &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stribild &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Truvada &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Truvada &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Truvada &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">606</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other HIV</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other HIV</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other HIV</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue share</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;</sup></font><font style="font-family:inherit;font-size:9pt;">&#8211; Symtuza</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; U.S</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue share</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;</sup></font><font style="font-family:inherit;font-size:9pt;">&#8211; Symtuza</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue share</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;</sup></font><font style="font-family:inherit;font-size:9pt;">&#8211; Symtuza</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2) </sup></font><font style="font-family:inherit;font-size:9pt;">&#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total HIV &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,253</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,830</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total HIV &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">639</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">569</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total HIV &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,618</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">AmBisome &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">AmBisome &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">AmBisome &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">119</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.33840304182509%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GILEAD SCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRODUCT SALES SUMMARY - (Continued)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ledipasvir/Sofosbuvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ledipasvir/Sofosbuvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ledipasvir/Sofosbuvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3) </sup></font><font style="font-family:inherit;font-size:9pt;">&#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Letairis &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ranexa &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Sofosbuvir/Velpatasvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(4)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Sofosbuvir/Velpatasvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(4)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">154</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Sofosbuvir/Velpatasvir</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(4)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vemlidy &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vemlidy &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vemlidy &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">136</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">101</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Viread &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Viread &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Viread &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vosevi &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vosevi &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vosevi &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Yescarta &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Yescarta &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Yescarta &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zydelig &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zydelig &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zydelig &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font><font style="font-family:inherit;font-size:9pt;">&#160;&#8211; Other International </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total product sales &#8211; U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,989</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total product sales &#8211; Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">927</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">882</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total product sales &#8211; Other International</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">____________________</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Includes Emtriva and Tybost </font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Represents Gilead&#8217;s revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by Gilead&#8217;s separate subsidiary, Asegua Therapeutics LLC</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by Gilead&#8217;s separate subsidiary, Asegua Therapeutics LLC</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;Includes Cayston, Hepsera and Sovaldi</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gild-20200430.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gilead.com/20200430" xmlns:gild="http://www.gilead.com/20200430" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200430_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200430_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverCover" roleURI="http://www.gilead.com/role/CoverCover">
        <link:definition>0001000 - Document - Cover Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>gild-20200430_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.gilead.com/role/CoverCover" xlink:href="gild-20200430.xsd#CoverCover" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.gilead.com/role/CoverCover" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>gild-20200430_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.gilead.com/role/CoverCover" xlink:href="gild-20200430.xsd#CoverCover" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.gilead.com/role/CoverCover" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>gild-20200430_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4_label_en-US" xlink:label="lab_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="lab_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433_terseLabel_en-US" xlink:label="lab_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433_label_en-US" xlink:label="lab_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:to="lab_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:to="lab_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C_label_en-US" xlink:label="lab_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:to="lab_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:to="lab_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A_label_en-US" xlink:label="lab_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:to="lab_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:to="lab_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:to="lab_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:to="lab_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:to="lab_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:to="lab_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2_label_en-US" xlink:label="lab_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:to="lab_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:to="lab_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA_label_en-US" xlink:label="lab_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:to="lab_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC_label_en-US" xlink:label="lab_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:to="lab_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:to="lab_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364_label_en-US" xlink:label="lab_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:to="lab_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7_label_en-US" xlink:label="lab_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:to="lab_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A_label_en-US" xlink:label="lab_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:to="lab_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:to="lab_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:to="lab_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE_label_en-US" xlink:label="lab_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:to="lab_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>gild-20200430_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.gilead.com/role/CoverCover" xlink:href="gild-20200430.xsd#CoverCover" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.gilead.com/role/CoverCover" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_DocumentType_80B9F58E45F35F08A0F0C22CB38E5433" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_DocumentPeriodEndDate_3DE26AAC7523E620F8F5C22D1B5BE9F9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityRegistrantName_4A72FDA870BFCA42D31BC22D84A6E79C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7AA7E6F3983722B72B14C22E30593167" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityFileNumber_D642D1FAF9DC76D8E134C22E8010813A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityTaxIdentificationNumber_DFB59B0E6699CE6BD9FFC22EC308A34B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityAddressAddressLine1_83CBE8DE0618DB13231BC22F42DB3317" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityAddressCityOrTown_29C022047CECE7A3A7BAC22F9BB2EE6F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityAddressStateOrProvince_6383C153A30E3E942DF5C2300850BB1A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityAddressPostalZipCode_7220D80728E98011458DC2305C79B509" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_CityAreaCode_CF05996C3549F969F6B5C230ACCE0FF2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_LocalPhoneNumber_7E8EC41480C05AA8DF4EC231036C8BF8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_WrittenCommunications_B9FA1CA777C4DD1C39D0C2316F73DAFA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_SolicitingMaterial_893C909DD5F11ECEB6A5C231D6EB5FEC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_PreCommencementTenderOffer_62BB9B8A0C6DBA4E7062C2321A286852" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_53C415C26DBCF513CE1DC23294B4EB65" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_Security12bTitle_23785AB01E3F75CFBA61C232F7835364" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_TradingSymbol_78C1325A722E82239A26C23331263BE7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_SecurityExchangeName_579B2ABF7D7F46BAF20EC233758DFD2A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityEmergingGrowthCompany_0FDD9EA7C948ADFD7427C233D7BB3439" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_EntityCentralIndexKey_00542C904F6E14C30676C23672DCE505" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8E8DF32DBAD6053DFCCEC22C82268FA4" xlink:to="loc_dei_AmendmentFlag_78FD515CB51547DA5D97C236CFEA8EEE" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gileadlogocolora001a18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gileadlogocolora001a18.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '*!B\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDDK(_&:E2=6;J5&W)[MZMCJ2BEH("BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>'_^A1U/_O\ QU\.Z?HVH:J<65C<WAR1BWA9^0,GH*Z2Q^#GCS4V M?!>OS
M_P 0TR;9TS]XKC]:I8FO+;\CEJ<)<.4?XGN^LVOU/K__ (>+>'_^A1U/_O\
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M<DH^E[-_-Z?(^LJ6BBND^/"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!#U%?G=_P4$_Y+5IG_8"A_P#2BXK]$3U%?G=_P4$_Y+5IG_8"
MA_\ 2BXKCQ7\)GW_  -_R.J?I+\CQ3X,_P#)8? O_8=L/_2B.OU[3[B_2OR$
M^#/_ "6'P+_V';#_ -*(Z_7M/N+]*QP7P,]OQ%_WZC_A_4=1117I'Y*%%%%
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ME-.7SV7YW^1Y!7WY_P $[O\ DFOB3_L+G_T3'7P'7WY_P3N_Y)IXD_["Y_\
M1,=>=A/XJ/U;CO\ Y$TO\4?S/K*BBBO>/YI"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!#U%?G=_P4$_Y+5IG_8"A_\
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MWL[!5S_W]=*Y&]_X*<^$8L_8_!VMSC''GS0Q<]AP6X]Z /M&BOAK_AZ)I?\
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M .4F^_\ C% 'O=%>"?\ #=7P/_Z'?_RDWW_QBC_ANKX'_P#0[_\ E)OO_C%
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M"_\ T)6K_P#@5%6I;?\ !3/X>ER+CPWXFC3'!CBMW.?H9A_.@#[!HKYATO\
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M2:>)/^PN?_1,=:X3^*CP.._^1-+_ !1_,^LJ***]X_FD**** "BBB@ HHHH
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MD&LVB@#Z)\ ?MY?%KP4\4=WJT'BBR7 ,&LP!VQWQ*FU\^[$_2OJCX5?\%%/
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M10!^47[?G_)SGB'_ *]K/_TG2OG:OHG]OS_DYSQ#_P!>UG_Z3I7SM0 4444
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M;LKLJG3E5G&G!7;=EZL^)/V]/BP?$7C.T\%6,V;#1@)[O:>'N77@'_<0_F[
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MZ!?\$O/^0#\0?^OFR_\ 0)J^Y*^&_P#@EY_R ?B#_P!?-E_Z!-7W)0 4444
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M!EK_ /(U'_#L[X8?]![Q=_X&6O\ \C4 ?FA17Z7_ /#L[X8?]![Q=_X&6O\
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MYN^P@E)ZR]E;^/H?FP6 /MJBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK\7/@[X9\2M)OO)[40WOM<Q_)+QVRREA[,*])H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC?B)\)/!_Q7T[[%XK\/V>
ML1@;4EE3;-%_N2KATZ]B*[*B@#\X?CS_ ,$\]:\*17.L?#NXF\1Z:F7?2)P/
MML0_Z9D8$P'I@-V 8U\=3P26L\D,T;Q31L4>-UVLK#@@@\@@]J_>.OF?]JG]
MCW2/C7I]QKOA^*WTGQQ&N1-C9%J '\$V/XNPDZ] <C& #\L:*O:WHE_X;U>\
MTO5+.:PU&TE:&>VN$*O&X.""#5&@ I\,TEO*DL3M%+&P9'0D,I!R"#V-,HH
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M:(^VYUF:.PCQUP3O?CTV(P_$5^:5>/CI7:CV/WKP[P?)A:V+:UDTEZ)?YO\
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M_P $O/\ D _$'_KYLO\ T":ON2@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?(G[>'[-47Q!\+3^/- M/\ BIM(AW7L4*\WUJHY)'=XQR#U*@CG"@?F
MI7[RD!A@C(K\AOVOO@['\&OC/J=A8P>3H>I :CIJ@?*D;D[HQ_N.&4#KMVGO
M0!XG1110 5^AG_!-?XLMJOAO6_A_?3;IM+;^T=/#-D_9W;$J >BR%6^LQK\\
MZ]5_9=^(3?#+X[^$M9>3R[-[M;*[R<+Y,W[MB?9=P?ZH* /V1HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 0]17YW?\%!/^2U:9_V H?_ $HN*_1$]17Y
MW?\ !03_ )+5IG_8"A_]*+BN/%?PF??\#?\ (ZI^DOR/%/@S_P EA\"_]AVP
M_P#2B.OU[3[B_2OR$^#/_)8? O\ V';#_P!*(Z_7M/N+]*QP7P,]OQ%_WZC_
M (?U'4445Z1^2A1110!YG^TC<"U^!7CAR2 =+G3Y>N67:/YU^3M?J]^TM;FY
M^ _C=%(&--E?GT4;C_*ORAKQL;\:]#]\\.;?4J_?F_1!1117FGZX%%%% !11
M10 4444 %?IO^Q_\*&^&7PHM);R#R]9UHB_N@PPR*P_=1G_=3!([,S"OB#]F
M/X6GXL?%K2]/GA\[2;(_;K_/W3&A&$/^^Q5<>A)[5^J: * !Q@5ZV"I[U&?B
M?B#FWP9;3?\ >E^B_7[A]%%%>J?B84444 %%%% !1110 4444 %%%12R"*)G
M) 51DDG  H&M=#X+_P""A/C;^T?&V@>%X7S'IMJUW-M_YZ2G !]PJ9^DE?)5
M=I\9/'!^(WQ0\2>(MQ:*]O&\@]Q"F$B'_?"K7%U\W7GSU'(_K;A_ _V=EE##
MM6?+KZO5_BPHHHK ^A"OOS_@G=_R33Q)_P!A<_\ HF.O@.OOS_@G=_R33Q)_
MV%S_ .B8Z[<)_%1^>\=_\B:7^*/YGUE1117O'\TA1110 4444 %%%% !1110
M 4444 %%%% !7XV?M/\ CYOB1\>/&&L"3S+5;UK.UQT\F']TA'U";OJQK]9_
MBEXI_P"$)^&WBKQ K8?3-,N;J/'4ND;%0/<L *_$8DL<DY- "4444 %?6O\
MP3H^%T?BSXJZAXLO8?,LO#=N#!N'!NI<JA]#M02'V)4^E?)5?JA_P3]\%IX6
M_9XT_463;<Z[>3ZA)D?,%#>2@^FV(,/]\^M 'TM1110 4444 %%%% !1110
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M/%IM_!>/$A 9Q'(KE0?4XK[W_P"'GOA?_H2M7_\  J*@#[5HKXJ_X>>^%_\
MH2M7_P# J*C_ (>>^%_^A*U?_P "HJ /M6BOBK_AY[X7_P"A*U?_ ,"HJ/\
MAY[X7_Z$K5__  *BH ^U:*^*O^'GOA?_ *$K5_\ P*BH_P"'GOA?_H2M7_\
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M()%'L!7Z\5\>?\%(OAC_ ,)#\-=*\96L.Z[T"X\FY8#G[-,0N3_NR"/'^^U
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M/H?F/'N9?5<O6%@_>J.W_;JU?Z+T.XHHHKVS^=0HHHH **** "BBB@ HHHH
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M%J*%[+4+=[>4#J%88R#V(Z@]B!6[2;<DTK7T94)RIR4X.S6J]3\</&OA&_\
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MK\<K"SO)O+TGQ$@TN<GHLK,# Y_X'A<]@Y- 'ZOT444 %%%% !1110 4444
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M)>?\@'X@_P#7S9?^@35]R4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'S-_P4,_Y-NO?^PE:?\ H1K\LJ_4W_@H9_R;=>_]A*T_]"-?EE0 4444 =;\
M(?\ DK/@K_L-V7_H]*_;FOQ&^$/_ "5GP5_V&[+_ -'I7[<T %%%% !1110
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M_P"3A/B'_P!ANZ_]&&O,Z "BBB@#]/O^"<'_ ";Y<?\ 8;N?_1<-?5%?*_\
MP3@_Y-\N/^PW<_\ HN&OJB@ HHHH **** "BBB@#\HOV_/\ DYSQ#_U[6?\
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MB3]HF;61HEY9:;;Z6L9FN;_>$9G+;47:IR<*2?3CUKQ^OUC_ &'/AI_PKKX
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M* /QE_:9_P"3A/B'_P!ANZ_]&&O,Z],_:9_Y.$^(?_8;NO\ T8:\SH ****
M/T^_X)P?\F^7'_8;N?\ T7#7U17RO_P3@_Y-\N/^PW<_^BX:^J* "BBB@ HH
MHH **** /RB_;\_Y.<\0_P#7M9_^DZ5\[5]$_M^?\G.>(?\ KVL__2=*^=J
M"BBB@#] O^"7G_(!^(/_ %\V7_H$U?<E?#?_  2\_P"0#\0?^OFR_P#0)J^Y
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YF_X*&?\FW7O_82M/_0C
M7Y95^IO_  4,_P"3;KW_ +"5I_Z$:_+*@ HHHH ZWX0_\E9\%?\ 8;LO_1Z5
M^W-?B-\(?^2L^"O^PW9?^CTK]N: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^=_VZ/BA_PKGX"ZI:V\OEZGXA8:3 %/S"-P3,V.N/+#+GL76O
MRAKZH_X*'_$[_A,/C+%X;M)O,T[PS;"!@IRIN9,/*1VX7RD]BC5\KT %%%%
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MX _[!J_^A-7K= !1110 4444 %%%% !17DGQ-_:G^&GPG29-8\26USJ,8/\
MQ+-,(N;DL/X2JG"'_?*CWKXJ^-/_  4-\6^-$GTWP5;'P?I;DJ;S>)+Z1?\
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M_P"AAL__  66_P#\17U9^PG\>_&?QQ;QP?%^HPWYTO[#]E\JVCAV>9]HWYV
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M HHHH ^X_@A^W]X6^&GPQ\.^%M2\,ZQ<3:5:"W:YM7B99""3D!F! YKTI?\
M@IA\,2HW:#XM!QR!:6I _P#)BOS2HH _3U?^"C_PH903:^(U)[&QCR/_ "+3
MO^'C_P )_P#GW\1?^ ,?_P =K\P** /TIN?^"F7PXCC!M_#WBF5\\B6WMD&/
M7(G/\JY36/\ @J%I\8(TKX?W-P2.'O-36( _18VSV[BO@&B@#ZS\3_\ !27X
MDZLCQZ1I>AZ$AZ2+ \\H_%VV_P#CE>(>./VAOB3\2%=/$/C+5;VW<?/:QS>1
M;M]8H@J'\J\[HH **** "BBB@ HK7\+>$M:\;ZW;Z/H&F76KZG<'$=M:1%W/
MJ3CH!W)X'<U]_?LV_L!6'A*6V\1?$=;?6-60B2'1(SOM;<]093TE;_9^X/\
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MT445T'S@AZBOSN_X*"?\EJTS_L!0_P#I1<5^B)ZBOSN_X*"?\EJTS_L!0_\
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MY_\ 1<-?5%?+G_!.NTGLO@#<1W$,D$G]M7)V2*5./+B[&OJ.@ HHHH ****
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M!,&FQ0GKG^ #GWK%N?V//@W=R!W\!Z>I Q^ZDFC'Y*X%>S44 >*_\,8_!?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA_\ 2BXKCQ7\)GW_  -_R.J?I+\CYCHHHKP#^F0HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 )B@@$<BEHH ^=?VB/V2-'^+0GUK0_*T7Q5M
MR9=N(+P^DH'1O]L<^H;C'Y[>+_!NM> M=N-'U_3YM-U" X:*8=1V93T93V8$
M@U^R //O7"_%7X.>&?C#H1T[Q!8B1D!\B\C^6>W8_P 2/V]P<@]P:X:^%53W
MEHS](X<XQKY4XX?%7G2Z=X^G=>7W'Y1>&_$VJ^#]9MM6T6_GTW4;9MT5S ^U
MAZCW!Z$'@@X(Q7W;\ ?VVM*\9K;Z'XV:'1-<.$CU#.VUN3_M$_ZICZ'Y3V(R
M!7S#\<OV8O%/P5N9+J2(ZMX<9\1:K;(<(.PF7DQMT]5/8YXKQRO-A4J8>5G]
MQ^N8W+<JXKPJJQ:;Z2CNO+_-,_:E9%D4,IW ^E/%?F;\"OVN?$_PC\G3=1+^
M(?#2X7['-)^^MU_Z92'H!_<.5]-O)K[Y^&/Q@\+_ !<T?[?X<U)+HJ!YUJ_R
M3P'T=#R/KR#C@FO8I5X5=MS\%SKAO'9+-NJN:'22V^?9^IW=%%%=!\J(>HK\
M[O\ @H)_R6K3/^P%#_Z47%?HB>HK\[O^"@G_ "6K3/\ L!0_^E%Q7'BOX3/O
M^!O^1U3])?D?,=%%%> ?TR%%%% !113XXVE=412[L<*JC))]!3$VEJQE>G?!
M7]G_ ,3_ !NU?RM+A^QZ1"X6YU:=#Y,/JJ_WWQ_"/;) YKV3]G_]B34/$[6^
MN>/4FTK2N'CTD?)<7 Z_O#UC7IQ]X\_=X)^Y="T'3?#6DVVF:19PZ?86R[(;
M>W0(B#V _/WZUZ%#".7O3T1^4<0\;TL)S8;+FI3ZRW2_S?X'(?"#X)>&_@MH
M?]GZ';;KF4 W5_/@SW##NS=@.<*.!GU))]#P<GM2J/:C /%>S%**LC\%KXBK
MB:DJU:3E*6[>XZBBBF8A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 E!Z4M% %2[M(;^VDM[B-)H95*O&ZAE8'@@@]17R-\=OV&++6&GU
MGX?&/3;QB7;19#MMY#W\MO\ EF?]D_+[J!7V$3@TE9U*<:JM)'K9;FV+RFK[
M7"SMW71^J/QH\1^&M5\(ZO/I>M:?/IFH0'$EO<1E''H>>H/4$<'M1X<\2ZKX
M1U>#5-%U"?3-0@.8[BWD*./4<=0>A!X/>OUA^)?PB\+_ !:T?^S_ !'ID5YM
M!\BZ7Y)X">Z..1ZXZ' R#7PO\9_V+/%?P[-QJ/AT2>*="4EOW"?Z7 O^W&/O
M@?WDST)*J*\BIA9T_>AJC]VR?C' 9O'ZMCDH3>EG\+^;[]F>I?!7]O."Y-OI
M?Q#MQ;2_=&M6B9B;T,L8Y7_>3(_V0.:^O=$UW3_$>F6^H:7>P:A8SKOBN+:0
M.CCU##@U^,K*58JP((."#U%=G\-?C#XM^$VI"[\-ZM+:(2#+:2?O+>?_ 'XS
MP3VR,,.Q%52Q<HZ3U1P9SP'A\4G6RU\DOY7\+].J_%>A^NY&2*_._P#X*"'/
MQJTO_L!0_P#I1<5[7\(_VZ_#'BTP6/B^#_A&-2;"_:<E[.0^N[JG_ L@?WJ\
M+_;SO[;5/B]HUU9W$5U;3:# Z30.'5U,]Q@JPX(]ZZ<14C4HMQ9\KPKEF+RS
M/84\73<7:5NSTZ/9GS91117B']"A15_1-"U'Q+J<.G:38SZC?S-B.WMHS(['
MV K[ ^"G[!DDI@U7XBSE$X==$LY.3[32KT_W4/\ P+M6U.E.J[11\_FV>8')
MZ?-BIV?1+63]%^NQ\T_"[X,^*_C!JOV3P[IK2PHP6>^EREO![N_KSG:,L>P-
M??OP-_9.\+_!]8M0N%77O$P SJ-Q& L)_P"F2<[?]XY;W .*]B\/^'M-\+:9
M!IND65OIUA NV.VMHPB*/H/\FM08KV*.&C2U>K/P//>+\9F]Z-/W*79;OU?Z
M;"@ #%&*6BNT^#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>11
<FILENAME>0000882095-20-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000882095-20-000009-xbrl.zip
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M A0FGOL (/ !'28;P:1LG)@O'P)W".<A&$ETP%U*L7C&=_0QD0-N.V;_&,&
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MT!BZMNT^P7=P0GR$,F?/@GM5M(Y4\2_<?C@ZEH\[/"PY]96OCLY SE?!Z&[
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MI=SCHFD:J0AS'@2>U0]5=%[@1LE:FN(\;^=82_%'"_'&J+1:6<0;4@X(_45
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M?QQIQ(K:]>YV)-.=LZ)VM[;=D1:!%9EB@!C?*B=2Y,YV 5F,PQ'C#T)F^?M
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MAKCYR!U4UMF3ZWT' 'DN7! <T"C;=F/DM>WB7(0W9GS<E^#RF8W(=$-I$;*
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M5!0/X:H<FB2< :"0P\8;;?;]X2C"TQFL<?PPRT_Q$)A"%<B?&SQ/K$$%MSM
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M(7.3@9N)+)   N:41&U&HUR(L\^E 'NGZ"E00BL*[U#$#Y,WXF"Z[+5O\'#
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MM!I93&^ZLA!"U/X1U3W)$Z)(75E&TFW7]QD/ L_JAZI=5^ RQW5DU4=79NX
MV5<A 23ID:0GG3A9[%[DPZ'#4,3#\*XNG/R<!=*3Q );_6+9@F>IG5, ^K#&
M>6C >3#=$!=M)XD6VX)]IJKM;YWIOI7%UN8E"I?,CK1).F!TP*3NW-[<$Z#1
M =.J4674F+JU3;:N*5%YOZEJ5?^1=IAV>"O3)J/@"_K+1'C,'W%OE28#B!F/
M70=>X@Z^CUP;6)//JJS/?6M YI'=DA%J5K5%:>RXGLFBJ9MOF@X8'3!-#U@K
MD[:CVP$KK5'S#J4 GX6^,$$X2 D&,/-!:,OZ$QMP_@+0G]P[\^LG6>*W=&5U
MA"@-$)6IAJ/VM)TTP3=K@J9EAX&@;A$DJN9(5*U3<24Z8'3 =J@+9BI.J-L!
M(UWP95TP.^\O  4J@.R>ITQ40E0.$-7)4[8\:8/SL#SC_@B(^J,%CS9]9HJ!
M#43?G-)_$D))",V+$%H[SI2ZI)T02@>,#IBN!ZP0+G4I!WR0UL[D>_EO:C2V
MY8AJ%*]DU&L_?WR7X=$ Y#_R6_G7R(N?-^$/HMKW!/]>Y<- >*?<?N+/_D%T
M"V<.'\//?-$TV^UZM]5M=LUFO=[D9KO..URTC9K1,;B &S[PF;=EG'-][3G7
M=[+HJ;MG"&1MB>"8?KSC>F-NSU 6HZ;HB'($#(1M1U?_=E [D)]!71G$GY=,
M^MX:"Y]=BR=VZX[Y K=XLLQ@=-IM'S<:G6:M46L:G7JKUOTY#H$&\F#SB2].
MXS\6IG^0"/"IP,;5XKUZ8:/Y\\>#!6(576N\[=I>8Z%W</)Z$\^R6:-68?5:
M/8M9@(2-C?9Q>SV3<Q*X7]^JXJK)AM)<=S_7E=+:4H'AC;QT(+#\P>;CEA^?
MU#OZKFW"([Y<7EWTSMG=V>7%]=G%785=7I\=9V+X.QSD[<79S?79Y=5E[_[R
MYIK=?&9?>KUO[/Z&7=]<5^7?GR^O>_"3WA5,X//-[5?YRW@>FX_@%S^<K  Q
M@/3CPKI,G]B>!%BOX.B7#_"(I;C9__H>A@X/32L0YM';AS9W*)NQ +?[T5H.
M@UML;#A58>+'0$P"M 'B*T'L5@T/4^$B8U#F G_W,\N1:#OFWH/EJ.'Q,'#C
M+Q0UE=\HH=*HU3:3=[NORKOMD]4RK9'I4G?;#]SX75J).$5G]3N>7P+M]GNZ
MP1:H3G?=J7674]/[D2<$^PH71CZ[  JUS%].^"W._-Z,WW=M/;HS?'_EWF#$
M&D:%8%WH^;TY=7@7L%[#E+(SH)?7,D9;7S.R&=;&L#^VR(<5>,F\SUP_8.Z0
M/;BNZ>->FLP3 ]<96+8E@P!/Z4"\PURC8R45UU=:=A/3HXW>C<WU+73N76-1
M=N &DY;.P0+1HZ@<BLK)2U1.]V29I)*[H!PZ7W2^]#Q?K4S5@'4[7WJE-FUA
MGKW!OT++MU IJ7K"YH$PV5__TJD;QD?T4,'4_JW2EH"S3T)O,.(JN2G@SH/5
MMZE#8RYS3@[K)UD*$"QNPB:SV6>]>8+@_B&8*>LI/Q LC?9W#:R#-,"-)=2=
M%*)>N9IKF$QTD6]?6Y]-!.!LR[$U8MC.U"\Y^XKL=_=)=R7*0)3A;>MQTLY4
M$J18E$&K> @JL%XHA]&KG2)H_XNW_UI,N_!A$-\\UPP' 0-&X_M,A7)3((1V
M<"\Z%:.]I'"&]<,9)DN(%RFMV2S0.6M<VJD?;[5"AYXV:[6S/Q.FRX%IXSB+
MQR]GF%Z&YHQB-KGLBR2[K'6RWS._:&L'O'F<*8#MC7/5ZYAG9UV$8]UQW#K>
MW."=%QQOQ*[RKF4E80,O:5IK/W73@AC-J" &B<7;(#I9?'%ZD:-.^]A@>_%)
MZD6J2%ND8S%[+&IT++)R\.+YLLHU5:U,_K3#M,/DCWZ+/_I6^$)67<%";*9X
M%+8[&0MXJO@Q$8XO?').:X?]HI,TVDMR3J_OG/9>HV2DIU%J<%Y2@XV*43.*
MD!Q,)XQ.F*8GK%:6]/N<^?)_GU2''MXD:Q?W74]Y[I&MV]8 6#F,9Q.F7@#*
MDO<\YVZ6DZ>GM9,R[7.)0*->[&(/V];]]&47-P%<V)MOO$&^\8W(PVM!*CGS
M <J8P_KF"<UK+ 1I=@3O=U.:R@#L8OE\4D%EN["0%N P;Q:<D<F.4[QR$CN;
M]38-/K7=U(W0L3P$G5LZM\4XM]U&O32GEL+DBCY5K8(/:(=IARE,[BUA<C<3
M@6XHYV%YR19-05\FI!>=@-%>4E#<^D%Q[AS=(CMN1CMNONRTS095:R%,%PS3
M]6Q9\/G"="FJM5"$5]'C:XSCXD1X4665_.(P&\_0$X?O41E%7YZQCPI?)";F
M4$P\[A1?2B3-ITR0SEC^*U^0WJ+BHRT/2R*Q5IGEUG[B'DM[E8E@O%^PR/;X
M8/>XDZ4:42;JL-]@"E+0"HKA5NTX2\1Q#B%,-;/T.;"%#16A#D^T_YKO_UYI
MWKL$$F&V(K.<@3L6[##R<1Q5F","JK15JD 4VLOBS+5D046K:1A9)'=[P*D"
MT#9K0+1*X"K(4I^$CB0=R;T<R<9)24IR+<6;OL[W*]?'4L"'#]QR_",V]-PQ
M$_\*K>"9^6(0PCV6\+,*  4@*@7O/U3O9(HF?F6N^SJ=A,>\X_'0R%1 +I\-
ML=ZCNI>VC&?J,2>=<QL"[F[*(N1+ MZXW<Y^(ZOKK7>=M*Y<FHXP'>&\'N%V
MK11'F (8BCY5K1P\M,.TP^_KS<N%$B4_S@8A7 R'8A!8CX(%_ ?S>" H]D [
ML!>=AM%>4NS!^K$'8H%TD>Y8BB2H>N,X4QW(?'GK*;&O3)@V3LI0IJ<4)4TN
ME6<"F9)B49B'SOMP4)@3^S"X^<_0#[#B.A4UV?Y<W\'MV#C.8GO7\U0>4;Y<
M'C%8R\0Q](3@>Q0TV0Y&MS#9Q).]6H-9^YE[S/XF<7,K?J@<)>,:W>-VEH3R
MS1<I1WF\I+_1@5I#^\O2@[)4YXGRXO41S,GI2#M,.TQNY95NY6L1Q!&Z/ @\
MJQ\&'!E3X+(OEBVX25YF[;!?=))&>TE>YO6]S,YKE(P4/$JJS4M2K5%IM3(U
M;M8MGIA.&)TP34]8MYTI*T>W$U8XMSQU&BFZ0S33P=.5@Q&<]@VG;I:20-J3
M:^K^0>)D*2(JZ_6MMDK0E4\0-',(S9-,6;^Z09-J6Y% ER>!KM[*$F2A*^$G
M/.T;3X=&]]UZ4NP^"+S42L6YY0\\$:A 7% 9O(>IGK#^@=XP%K=.L;AED@8;
M6TW\TI5=$3+SATQI5JEGJDRE&SP+Y\Z0W4/VQJ(:U"PPOW)K]F.M*W,A3.T;
M4X>D"14BYBW)3:2XMRU&Y;QOH<[]YNEH5\5SS[E=]8K1Z+[KFNQW_TD_)-I
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M50Y^5[9!/N*<NO6ZF6+"=:7UA*;]HJG3R5/J/(G[E/A<4A&KU2I$=BD!LW#
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M^8_\%O_ZCW@P?==\_O2?OWP8!6/[T_\/4$L#!!0    (  "!GE"MVN.;41H
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MF[&6X-+E#>#&Q[DW;GW_[X251I_*\@ +-TZPTE [YPI+<8Y.COX"4$L#!!0
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M%G7[<CZ[:;*3"IA(N*EIEZ93$SXI+D$V5E<6M@4.G B.@]A+GG9^G^])_WF
M CM9'U3P1W\&X$SQHXKO7X;X&^_T_CG+60%:#UJ B!HC>O/EX]X74$L#!!0
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M??^57Q;J,*.L/XWG?!3@V&<Y3F(O8P0'?HY@IH9) AS1."6ZOK JWK,NEIG
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M7=$;$S,[:.)P\DC[HQFWM+\5E,,WO%ULT7$QZ#>U^ES?[,N5*-<WD6*:4!+
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MWYAR2]/;83E\LUOF%ET7Q-/F?OP#/)&O/KY9?Z=8_G\H']_\'U!+ P04
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M"D <(;\YB@S1,%(8$!I6.D)1HG0,NA2):'2MQ3X@'(@)PE>MRU"YFB);[6'
M,QF?XTP2^XI6^D-$$Q$G/!"8**,%TUIWB?SHNHM=H/L>\7?S+=1._87W;QYO
MA$/XGY_W;_X/4$L! A0#%     @  (&>4(P9 K>06@  Y'$' !X
M     ( !     &5X:&EB:70Y.3%E87)N:6YG<W!R97-S<F5L+FAT;5!+ 0(4
M Q0    (  "!GE"MVN.;41H  /_(   :              "  <Q:  !F;W)M
M."UK<3$R,&5A<FYI;F=S<')E+FAT;5!+ 0(4 Q0    (  "!GE ;7+I5.0,
M %H1   1              "  55U  !G:6QD+3(P,C P-#,P+GAS9%!+ 0(4
M Q0    (  "!GE"(^6GO-0$  &L"   5              "  ;UX  !G:6QD
M+3(P,C P-#,P7V-A;"YX;6Q02P$"% ,4    "   @9Y0SJ- I)T!  "]!0
M%0              @ $E>@  9VEL9"TR,#(P,#0S,%]D968N>&UL4$L! A0#
M%     @  (&>4/I& :#""0  (V8  !4              ( !]7L  &=I;&0M
M,C R,# T,S!?;&%B+GAM;%!+ 0(4 Q0    (  "!GE">0NDPC 8   <U   5
M              "  >J%  !G:6QD+3(P,C P-#,P7W!R92YX;6Q02P4&
/  < !P#? 0  J8P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>form8-kq120earningspre_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gild-20200430.xsd" xlink:type="simple"/>
    <context id="D2020Q1Cover">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1Cover"
      id="Fact-7190B9B0D05C3A2EC0D6C236D012AE66-wk-Fact-7190B9B0D05C3A2EC0D6C236D012AE66">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1Cover"
      id="Fact-EFBEB44A60131AFBA631C23672EFEF38-wk-Fact-EFBEB44A60131AFBA631C23672EFEF38">0000882095</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q1Cover"
      id="d9904439e104-wk-Fact-DF82DCF05BAB832A1793C22CB3B9EC20">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1Cover"
      id="d9904439e144-wk-Fact-255D5D3DF8FEAE60F6A0C22D1B740727">2020-04-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1Cover"
      id="d9904439e187-wk-Fact-37A3595D653867DEBFF5C22D84AEAF5B">GILEAD SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1Cover"
      id="d9904439e207-wk-Fact-118C3651552539AFE738C22E30648673">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1Cover"
      id="d9904439e212-wk-Fact-20A8B0DC864BE2EFDE65C22E801CB591">0-19731</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1Cover"
      id="d9904439e217-wk-Fact-C8E6A5782E9B739EFD96C22EC312904B">94-3047598</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1Cover"
      id="d9904439e238-wk-Fact-F4FA22BB811F15F7E2E9C22F42E326B5">333 Lakeside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1Cover"
      id="d9904439e243-wk-Fact-BB1321B8A7E7DE6813E3C22F9BBBC632">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1Cover"
      id="d9904439e248-wk-Fact-404C5BBD50C47C5C3990C230085D1C28">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1Cover"
      id="d9904439e257-wk-Fact-E0F31D782567E1A9AA33C2305C8A0C36">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1Cover"
      id="d9904439e267-wk-Fact-4677EE869D4865770EA3C230AD01D01B">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1Cover"
      id="d9904439e271-wk-Fact-08FA5700662AF1094800C23103A5AC2D">574-3000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q1Cover"
      id="d9904439e327-wk-Fact-3776C3F408C418D58539C2316FAB3DD2">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q1Cover"
      id="d9904439e335-wk-Fact-0C7AA48C8579C8211A3EC231D6FDE33E">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1Cover"
      id="d9904439e343-wk-Fact-931C4D3BA33B787DC0C6C2321A5EC9CB">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1Cover"
      id="d9904439e351-wk-Fact-28ABB04CC31D407D8BA8C23294C3C141">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q1Cover"
      id="d9904439e404-wk-Fact-70F24BF8C620FD66F9EDC232F78F5614">Common Stock, par value, $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1Cover"
      id="d9904439e414-wk-Fact-A2982D9EA0846DE0CEA5C233313362C1">GILD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1Cover"
      id="d9904439e424-wk-Fact-864EB48A93A357C64B7EC2337598C76B">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1Cover"
      id="d9904439e432-wk-Fact-05274D557B34F5ACE0E8C233D7ECA287">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6608515344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Cover<br></strong></div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GILEAD SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3047598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Lakeside Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value, $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GILD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-kq120earningspre.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CoverCover</Role>
      <ShortName>Cover Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-kq120earningspre.htm">form8-kq120earningspre.htm</File>
    <File>exhibit991earningspressrel.htm</File>
    <File>gild-20200430.xsd</File>
    <File>gild-20200430_cal.xml</File>
    <File>gild-20200430_def.xml</File>
    <File>gild-20200430_lab.xml</File>
    <File>gild-20200430_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-kq120earningspre.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "gild-20200430_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gild-20200430_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-kq120earningspre.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gild-20200430_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gild-20200430_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "gild-20200430.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "gild",
   "nsuri": "http://www.gilead.com/20200430",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-kq120earningspre.htm",
      "contextRef": "D2020Q1Cover",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Cover",
     "role": "http://www.gilead.com/role/CoverCover",
     "shortName": "Cover Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-kq120earningspre.htm",
      "contextRef": "D2020Q1Cover",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CoverCover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_A=A=UH[-[^8^.+H.S@UUW(+U!+ P04    "   @9Y0F5R<(Q &  "<)P
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M,I]8-QC*G)REOL_I_I_5P8M^^1M02P,$%     @  (&>4+JA.8K7 0  ,@8
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M[^?6T/!!XG-8\1S,Z6Y_"B]-\K!EG3>*G.[V9ZC%H-[.!?>_1/$#4$L#!!0
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M!CW4;T(6!)>%JS6K_DH\X_N'T:,8>[!V(=B[?R63^'N.X9/F/U!+ P04
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ML)\)VV$]=N'?(*EA.N_6_VATF<N@7?S-R$=*[4%?#?_)\@M02P$"% ,4
M"   @9Y0'R// \     3 @  "P              @ $     7W)E;',O+G)E
M;'-02P$"% ,4    "   @9Y0)^B'#H(   "Q    $               @ 'I
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  "!GE ,EF4A[@   "L"
M   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   (  "!GE"97)PC$ 8  )PG   3              "  ;8"  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @  (&>4(XMSN"? @  F L  !@
M         ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   (  "!GE#-E(["4P(  .X%   4              "  <P+  !X;"]S:&%R
M9613=')I;F=S+GAM;%!+ 0(4 Q0    (  "!GE"ZH3F*UP$  #(&   -
M          "  5$.  !X;"]S='EL97,N>&UL4$L! A0#%     @  (&>4)^:
MJR(Y 0  * (   \              ( !4Q   'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    (  "!GE#_P"8(O0   (4"   :              "  ;D1  !X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  "!GE +C]@#
M(0$  %<$   3              "  :X2  !;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@     *  H @ (    4      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
